Champions Oncology
(NASDAQ) CSBR
Champions Oncology Financials at a Glance
Market Cap
$87.76M
Revenue (TTM)
$57.94M
Net Income (TTM)
-$2.28M
EPS (TTM)
-$0.17
P/E Ratio
-37.94
Dividend
$0.00
Beta (Volatility)
0.39 (Low)
Dividend
$0.00
Beta (Volatility)
0.39 (Low)
Price
$6.50
Volume
5,178.159
Open
$6.72
Price
$6.50
Volume
5,178.159
Open
$6.72
Previous Close
$6.32
Daily Range
$6.32 - $6.76
52-Week Range
$5.50 - $9.63
Estimated Earnings Date
Jul 16, 2026
Dividend
$0.00
Beta (Volatility)
0.39 (Low)
Price
$6.50
Volume
5,178.159
Open
$6.72
Previous Close
$6.32
Daily Range
$6.32 - $6.76
52-Week Range
$5.50 - $9.63
Estimated Earnings Date
Jul 16, 2026
CSBR News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Champions Oncology
Industry
Life Sciences Tools and Services
Sector
Health CareEmployees
213
CEO
Robert Brainin
Website
www.championsoncology.comHeadquarters
Hackensack, NJ 07601, US
CSBR Financials
Key Financial Metrics (TTM)
Gross Margin
46%
Operating Margin
-4%
Net Income Margin
-4%
Return on Equity
-47%
Return on Capital
-29%
Return on Assets
-8%
Earnings Yield
-2.64%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$87.76M
Shares Outstanding
13.89M
Volume
5.18K
Avg. Volume
9.11K
Financials (TTM)
Gross Profit
$28.56M
Operating Income
$4.85M
EBITDA
$6.27M
Operating Cash Flow
$7.39M
Capital Expenditure
-$389.00K
Free Cash Flow
$7.00M
Cash & ST Invst.
$9.79M
Total Debt
$6.11M
Champions Oncology Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$16.56M
-2.8%
Gross Profit
$7.73M
-25.9%
Gross Margin
46.65%
N/A
Market Cap
$87.76M
N/A
Market Cap/Employee
$417.93K
N/A
Employees
210
N/A
Net Income
-$279.00K
-106.2%
EBITDA
$104.00K
-97.9%
Quarterly Fundamentals
Total Cash
$7.13M
+122.6%
Total Debt
$5.00M
-22.3%
Accounts Receivable
$12.07M
-23.5%
Inventory
$0.00
N/A
Long Term Debt
$3.39M
-32.2%
Short Term Debt
$1.61M
+12.1%
Return on Assets
-8.02%
N/A
Return on Invested Capital
-28.61%
N/A
Free Cash Flow
-$1.38M
-407.1%
Operating Cash Flow
-$1.34M
-373.3%